John R. Saksa

Riluzole Augmentation in Treatment-Resistant Obsessive–Compulsive Disorder: An Open-Label Trial

Vladimir Coric, Sarper Taşkıran, Christopher Pittenger et al. · Biological Psychiatry · 2005 · 308 citations

Psychiatry, Riluzole Augmentation, Medicine +6

High dose D-serine in the treatment of schizophrenia

Joshua T. Kantrowitz, Anil K. Malhotra, Barbara A. Cornblatt et al. · Schizophrenia Research · 2010 · 242 citations · Full text

Psychiatry, Psychotic Disorder, Medicine +9

Orbitofrontal cortex neurofeedback produces lasting changes in contamination anxiety and resting-state connectivity

Dustin Scheinost, Teodora Stoica, John R. Saksa et al. · Translational Psychiatry · 2013 · 204 citations · Full text

Biofeedback, Neuropsychology, Contamination Anxiety +23

Incidence of Tardive Dyskinesia With Atypical Versus Conventional Antipsychotic Medications

Scott W. Woods, Hal Morgenstern, John R. Saksa et al. · The Journal of Clinical Psychiatry · 2010 · 183 citations

First-Episode Services for Psychotic Disorders in the U.S. Public Sector: A Pragmatic Randomized Controlled Trial

Vinod H. Srihari, Cenk Tek, Suat Küçükgöncü et al. · Psychiatric Services · 2015 · 131 citations